Patient organizations oppose Orphan Drug tax credit reform

The National Organization for Rare Disorders (NORD) and 35 other patient groups released a joint statement Tuesday opposing the Senate Finance Committee’s proposal to cut the Orphan Drug tax credit. The groups argue the proposal will "substantially weaken" drug development incentives for many rare disease populations...